US, UK Governments Approve Stryker-Wright Deal Pending Divestments

The agreements with the US Federal Trade Commission and the UK Competition and Markets Authority are the last regulatory hurdles in the way of Stryker’s planned $4bn acquisition of Wright Medical.

WASHINGTON, DC - SEPTEMBER 28, 2013: Federal Trade Commission Building in Washington, DC.

Stryker Corporation will divest its STAR total ankle replacement products and finger joint replacement products as part of an agreement with the US Federal Trade Commission (FTC) that clears the way for Stryker to complete its planned acquisition of Wright Medical Group N.V., the companies announced on 4 November.

Following the regulatory approvals, Stryker was able to close the acquisition of Wright on 11 November

More from Deals

More from Business